Tech Company M&A Transactions
TARIS Biomedical Acquisition
Headquartered in Lexington, TARIS Biomedical was bought by Johnson & Johnson. Johnson & Johnson did not announce any financial terms for the deal.
Transaction Overview
Company Name
Acquired By
Announced On
12/23/2019
Transaction Type
M&A
Amount
Unknown
M&A Terms
The TARIS technology and scientific team create an unparalleled convergence opportunity with real potential to deliver differentiated, targeted therapeutics for the treatment of patients with localized bladder cancer. Financial terms of the transaction were not disclosed.
Company Information
Company Status
Acquired or Merged
Industry
Biopharmaceutical
Mailing Address
113 Hartwell Ave.
Lexington, MA 02421
USA
Lexington, MA 02421
USA
Phone
Website
Email Address
Overview
TARIS Biomedical Inc., a specialty pharmaceutical company with deep domain expertise in therapeutics and drug-delivery, is focused on local minimally-invasive drug-device convergence products.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
Tony Kingsley
Chief Financial Officer
Diane Marcou
Chief Medical Officer
Christopher Cutie
Chief Scientific Officer
Dennis Giesing
Chief Technical Officer
Cheryl Larrivee-Elkins
Browse more venture capital transactions:
Prev: 12/21/2019: Willow venture capital transaction
Next: 12/24/2019: Weav Music venture capital transaction
Share this article
Where The Data Comes From
We do our best to report on all VC transactions involving tech companies. VC investment data records reported here are sourced from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs